Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carboplatin × Gastrointestinal × Clear all

Phase

Phase 2 68 Phase 1 39 Phase 1/2 23 Phase 3 16 Phase NA 3 Phase EARLY_PHASE1 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 18 Gynecologic 8 Breast 8 Genitourinary 4 Head & Neck 3 CNS 2 Sarcoma 1 Other solid neoplasm 1 Other neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Gastrointestinal 1 Endocrine 1 Dermatologic 1 Classical hematology 1

Conditions

Esophageal Neoplasms 1

Interventions

Oxaliplatin 41 Fluorouracil 40 Capecitabine 32 Cisplatin 29 Leucovorin 24 Gemcitabine 21 Drug Therapy 17 Bevacizumab 16 Folfox protocol 14 Radiotherapy 12 Paclitaxel 12 Irinotecan 12 apatinib 10 Docetaxel 9 Neoadjuvant Therapy 8 sintilimab 7 Surgical Procedures, Operative 7 Sorafenib 7 Nivolumab 7 lenvatinib 6 XELOX 6 S 1 (combination) 6 Magnetic Resonance Spectroscopy 6 Cetuximab 6 nimotuzumab 5 camrelizumab 5 Trastuzumab 5 Radiosurgery 5 IFL protocol 5 Epirubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02741856 2018-10-25

SCOPE2

Velindre NHS Trust

Phase 2/3 Unknown

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡